New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
08:34 EDTIMMUImmunomedics announces U.S. patent for IMMU-144
Immunomedics announced the issuance of U.S. patent no. 8,722,047 for the company's patent application "Humanized anti-HLA-DR antibodies," with an expiration date of May 26, 2026. The new patent concerns compositions of humanized anti-HLA-DR antibodies of use for disease therapy. The allowed claims protect IMMU-114, which is being investigated as a monotherapy in a newly-opened Phase I dose-escalation trial in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukemia.
News For IMMU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
15:31 EDTIMMUImmunomedics volatility elevated
Immunomedics July call option implied volatility is at 199, August is at 176, November is a 145; compared to its 52-week range of 53 to 198, suggesting large price movement.
June 17, 2015
14:32 EDTIMMUImmunomedics options active
Immunomedics July 7 and August 4 calls are active on total call volume of 8K contracts (3K puts). June call option implied volatility is at 176, July is at 226, August is at 163; compared to its 52--week range of 53 to 173. Active call volume suggests traders taking positions for price movement.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use